<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Damas J</submitter><funding>Swiss National Science Foundation</funding><pagination>2469-2480</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8631148</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(15)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The aim of this study was to examine neurocognitive course over time among people with well treated HIV.&lt;h4>Design&lt;/h4>The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study is an ongoing, prospective, longitudinal, multicenter and multilingual study within the Swiss HIV Cohort Study (SHCS). Participants undergo neuropsychological assessment at baseline and two-yearly follow-up.&lt;h4>Setting&lt;/h4>Seven SHCS centres.&lt;h4>Participants&lt;/h4>Patients aged at least 45 years enrolled in the SHCS with fluency in the local language (French, German or Italian) and agreeing to participate in the NAMACO study: 981 participants at baseline, 720 at 2-year follow-up of whom 644 had complete data sets.&lt;h4>Intervention&lt;/h4>Standardized neuropsychological assessment at </pubmed_abstract><journal>AIDS (London, England)</journal><pubmed_title>Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.</pubmed_title><pmcid>PMC8631148</pmcid><funding_grant_id>192777</funding_grant_id><funding_grant_id>324730</funding_grant_id><pubmed_authors>Hundsberger T</pubmed_authors><pubmed_authors>Nadin I</pubmed_authors><pubmed_authors>Tarr PE</pubmed_authors><pubmed_authors>Ledergerber B</pubmed_authors><pubmed_authors>Kunze U</pubmed_authors><pubmed_authors>Assal F</pubmed_authors><pubmed_authors>Stoeckle M</pubmed_authors><pubmed_authors>Du Pasquier R</pubmed_authors><pubmed_authors>Rossi S</pubmed_authors><pubmed_authors>Schmid P</pubmed_authors><pubmed_authors>Damas J</pubmed_authors><pubmed_authors>Calmy A</pubmed_authors><pubmed_authors>Di Benedetto C</pubmed_authors><pubmed_authors>Darling KEA</pubmed_authors><pubmed_authors>Cavassini M</pubmed_authors><pubmed_authors>Schlosser L</pubmed_authors><pubmed_authors>Gutbrod K</pubmed_authors><pubmed_authors>Hauser C</pubmed_authors><pubmed_authors>NAMACO study group</pubmed_authors><pubmed_authors>Hasse B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.</name><description>&lt;h4>Objective&lt;/h4>The aim of this study was to examine neurocognitive course over time among people with well treated HIV.&lt;h4>Design&lt;/h4>The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study is an ongoing, prospective, longitudinal, multicenter and multilingual study within the Swiss HIV Cohort Study (SHCS). Participants undergo neuropsychological assessment at baseline and two-yearly follow-up.&lt;h4>Setting&lt;/h4>Seven SHCS centres.&lt;h4>Participants&lt;/h4>Patients aged at least 45 years enrolled in the SHCS with fluency in the local language (French, German or Italian) and agreeing to participate in the NAMACO study: 981 participants at baseline, 720 at 2-year follow-up of whom 644 had complete data sets.&lt;h4>Intervention&lt;/h4>Standardized neuropsychological assessment at </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-03-16T15:10:21.899Z</modification><creation>2025-05-29T22:25:42.602Z</creation></dates><accession>S-EPMC8631148</accession><cross_references><pubmed>34411034</pubmed><doi>10.1097/QAD.0000000000003057</doi></cross_references></HashMap>